Lassa fever outbreak in Nigeria is slowing, but remains a concern- WHO

Image result for Lassa fever in nigeria

After nearly 400 confirmed infections and 100 deaths, the spread of Lassa fever in Nigeria is beginning to slow but the epidemic is far from contained, the World Health Organization and the Nigeria Centre for Disease Control (NCDC) have warned.

NCDC’s latest data shows that the number of new confirmed and probable cases has been falling for five consecutive weeks, indicating that public health measures are proving effective, but more infections are expected until the end of the dry season, as the viral haemorrhagic fever is endemic to the area.

Between 1 January and 25 March 2018, the NCDC reported 394 laboratory confirmed cases. There were 18 new confirmed cases in the last reporting week (19-25 March 2018), compared to 54 confirmed cases a month earlier (19-25 February 2018).

“We should interpret the recent declining trend in new cases with caution. The Lassa fever season is not yet over. We need to maintain vigilance and response operations, and ensure continued engagement with communities to help curb the further spread of Lassa fever,” said Dr Wondimagegnehu Alemu, WHO Representative to Nigeria.

The current epidemic is Nigeria’s largest on record, with the number of confirmed cases in January and February alone exceeding the total number reported in the whole of 2017.

The case count has not yet fallen to usual endemic levels and the exact cause for the high numbers of infections has not been pinpointed. Research is being conducted in real-time to answer some of these questions.

“We are researching what has led to so many people becoming infected with Lassa fever,” said Dr Chikwe Ihekweazu, Chief Executive Officer of the NCDC. “Even with a downward trend, until we can better understand the causes behind its rapid spread, we must treat the outbreak as a priority.”
Whole genome sequencing can reveal information that contributes to the understanding and the control of infectious disease outbreaks.

Researchers at the Irrua Specialist Teaching Hospital – in collaboration with the Bernhard-Nocht Institute for Tropical Medicine, Germany, WHO, NCDC and others – have conducted genome sequencing of the Lassa virus.

The preliminary results suggest that the circulating virus is consistent with previous outbreaks and not caused by a new more virulent strain.

“By conducting research as the Lassa fever outbreak unfolds, Nigeria is a pioneering a new approach. Until now research in Africa has taken place much later in the response cycle. This is a new approach which opens the way to much more effective control of emerging and dangerous pathogens,” said Dr Alemu.

WHO recognizes Lassa fever as a priority pathogen which has the potential to cause a public health emergency. The ongoing research will provide crucial insights which will help mitigate future Lassa fever outbreaks.

WHO has been working with NCDC and other partners to control Lassa fever by deploying teams to hotspots, identifying and treating patients, strengthening infection, prevention and control measures in health facilities, and engaging with communities.

WHO has released US$900,000 from its Contingency Fund for Emergencies to quickly scale up operations, and is also supporting preparedness and response capacities in neighbouring countries.

WHO is supporting coordination for Nigeria’s response to Lassa fever with national health actors, and with partners in the Global Outbreak Alert and Response Network (GOARN) including: African Field Epidemiology Network (AFENET), Alliance for international Medical Action (ALIMA), the Bernhard Nocht Institute for Tropical Medicine, the Emerging Diseases Clinical Assessment and Response Network (EDCARN), the Federal Teaching Hospital Abakiliki, the Federal Medical Centre Owo, the Irrua Specialist Teaching Hospital, the Nigeria Red Cross Society, the Public Health Agency of Canada,  UNICEF, the United States Centres for Disease Control and Prevention and the University of  Maryland.


WHO’s response to Lassa fever in Nigeria is funded by the Contingency Fund for Emergencies and the European Commission.

Comments

Post a Comment

Popular posts from this blog

Unilever named most successful brand among FT500

Image
Unilever has been named as the most successful brand among the FT 500 for meeting its philanthropic goals, according to a recent study by Radley Yeldar. Unilever’s sustainability strategy was found to have made the biggest impact of all the companies listed in the FT 500 and the FTSE Eurofirst 100, having achieved the goals set out in its ‘making sustainable life commonplace’ mission statement. Radley Yeldar ranked the British-Dutch multinational consumer goods company number 1 on its Fit for Purpose Index 2015 which assesses and ranks companies based on how they live up to the altruistic promises set out in their brand purpose. The success of Unilever’s Bright Future project was the main driver behind its number 1 ranking. The ongoing initiative is a partnership with the WWF and promotes sustainable manufacturing of its products and a pledge of zero deforestation in doing so. In assessing the strength and impact of Unilever- whose brands include Dove and Dome
Read more

Nigeria now emerging hub for pharma market expansion in Africa

Image
A s growth opportunities continue to move away from traditional pharmaceutical markets and growth patterns in developed markets continue to flatten, many multinational companies (MNCs) like Norvatis, Pfizer, Sanofi, Johnson & Johnson, etc. look toward Africa, including Nigeria for their expanding global footprint. This is evident following GlaxoSmithKline (GSK) plan to invest over $200million in Africa over the next five years, expanding manufacturing in Nigeria and Kenya and building five new factories-Rwanda, Ghana and Ethiopia given its attractive long-term growth potential. With a growing middle class of expected annual disposable income in excess of $1 trillion by 2023, increasing awareness of healthier lifestyles, and a combined Gross Domestic Product (GDP) of $2.9 trillion, rising population growth is emerging as a melting pot for pharmaceutical expansion. Interestingly, of the four MINT countries (Mexico, Indonesia, Nigeria, and Turkey), Nigeria’s
Read more

Policy on healthcare waste management absent in Nigeria

Image
A cross section of medical waste disposal containers   …training of health workers on quality control imminent The sustainable management of healthcare waste (HCW) has over the years continued to attract increasing public interest especially public health and environmental experts given the health problems associated with exposure of humans to potentially hazardous wastes arising from healthcare. With these wastes said to contain materials considered harmful and can cause ill health to those exposed to it, often times, it has been shown that inappropriate handling and disposal of healthcare waste poses health risks to health workers who may be directly exposed and to people near health facilities, particularly children and scavengers who may become exposed to infectious wastes and a higher risk of diseases like hepatitis and HIV/AIDS. Even as considerable gap exist with regards to assessment of healthcare waste management practices in Nigeria compared with international best pra
Read more